Page 127 - 《中国药科大学学报》2025年第5期
P. 127
第 56 卷第 5 期 王亦玄,等:真空压缩成型技术在药剂学中的研究进展 659
流变学测试 其他应用
溶解度
黏度测定:
v v
剪切
均匀样品 含气泡样品 植入剂 差示扫描量热法
熔体拉伸试验:
均匀样品 常规形状的片剂
拉伸 粉末X射线衍射
含气泡样品
发生断裂 异形片剂 …
图 2 VCM 技术在制剂表征与检测中的应用
5 总结与展望 导报) 2023, 42(7): 984-988.
[7] Turpin ER, Taresco V, Al-Hachami WA, et al. In silico screen-
本文介绍了 VCM 技术的制备原理和优缺点 ing for solid dispersions: the trouble with solubility parameters
以及在药剂学中的应用进展。通过对比 HME 技 and χFH[J]. Mol Pharm, 2018, 15(10): 4654-4667.
[8] Meng F, Trivino A, Prasad D, et al. Investigation and correla-
术,运用案例分析说明 VCM 技术在 ASD 前期开发 tion of drug polymer miscibility and molecular interactions by
中处方工艺筛选的独特优势(物料用量少、样品制 various approaches for the preparation of amorphous solid dis-
备快速、清洗方便等),并介绍了其在药物递送系统 persions[J]. Eur J Pharm Sci, 2015, 71: 12-24.
[9] Lauer ME, Maurer R, Paepe AT, et al. A miniaturized extruder
和表征样品构建上的应用。然而,VCM 技术仍具
to prototype amorphous solid dispersions: selection of plasticiz-
有一定的局限性,它除了主要替代 HME 筛选载体 ers for hot melt extrusion[J]. Pharmaceutics, 2018, 10(2): 58.
外,在其他制剂应用方面案例较少,还不成熟。此 [10] Hörmann TR, Jäger N, Funke A, et al. Formulation perfor-
外,该技术目前还无法做到全自动化放大生产,其 mance and processability window for manufacturing a dual-
polymer amorphous solid dispersion via hot-melt extrusion and
在先进药物给药系统工业化开发方面的技术价值 strand pelletization[J]. Int J Pharm, 2018, 553(1/2): 408-421.
尚未充分体现,未来还需对 VCM 设备进行技术升 [11] Pöstges F, Kayser K, Stoyanov E, et al. Boost of solubility and
级,更好地应用于高端复杂制剂产品的开发。 supersaturation of celecoxib via synergistic interactions of
methacrylic acid-ethyl acrylate copolymer (1∶1) and hydrox-
ypropyl cellulose in ternary amorphous solid dispersions[J]. Int
References
J Pharm X, 2022, 4: 100115.
[12] Kayser K, Monschke M, Wagner KG. ASD formation prior to
[1] Treffer D, Troiss A, Khinast J. A novel tool to standardize rhe-
material characterization as key parameter for accurate measure-
ology testing of molten polymers for pharmaceutical applica-
ments and subsequent process simulation for hot-melt
tions[J]. Int J Pharm, 2015, 495(1): 474-481.
extrusion[J]. AAPS PharmSciTech, 2022, 23(6): 176.
[2] Meltprep. VCM Product Family. [EB/OL]. (2024-04-03)[2025-
[13] Jørgensen JR, Mohr W, Rischer M, et al. Stability and intrinsic
01-14]. https://www.meltprep.com/vcm-products.
dissolution of vacuum compression molded amorphous solid
[3] Wu HM, Zhang J, Luo MQ, et al. Recent progress on dissolu-
tion and absorption of amorphous solid dispersions[J]. Acta dispersions of efavirenz[J]. Int J Pharm, 2023, 632: 122564.
Pharm Sin (药学学报), 2022, 57(5): 1312-1321. [14] Shadambikar G, Kipping T, Di-Gallo N, et al. Vacuum com-
[4] Rusdin A, Mohd Gazzali A, Ain Thomas N, et al. Advancing pression molding as a screening tool to investigate carrier suit-
drug delivery paradigms: polyvinyl pyrolidone (PVP)-based ability for hot-melt extrusion formulations[J]. Pharmaceutics,
amorphous solid dispersion for enhanced physicochemical prop- 2020, 12(11): 1019.
erties and therapeutic efficacy[J]. Polymers (Basel), 2024, [15] Pöstges F, Lenhart J, Stoyanov E, et al. Phase homogeneity in
16(2): 286. ternary amorphous solid dispersions and its impact on solubili-
[5] Alzahrani A, Nyavanandi D, Mandati P, et al. A systematic and ty, dissolution and supersaturation - Influence of processing and
robust assessment of hot-melt extrusion-based amorphous solid hydroxypropyl cellulose grade[J]. Int J Pharm X, 2023, 6:
dispersions: Theoretical prediction to practical 100222.
implementation[J]. Int J Pharm, 2022, 624: 121951. [16] Dauer K, Wagner KG. Micro-scale vacuum compression mold-
[6] Li PL, Jia LN, Bu YR, et al. Research progress of continuous ing as a predictive screening tool of protein integrity for poten-
melt extrusion of pharmaceutical co-crystals[J]. Her Med (医药 tial hot-melt extrusion processes[J]. Pharmaceutics, 2023,

